KTTA Stock Price Prediction 2026-2027
AI-powered forecast for Pasithea Therapeutics Corp
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$0.74
Price Targets for 2027
Bear Case
$2.55
+243.5%
Base Case
$3.00
+304.1%
Bull Case
$3.45
+364.7%
Prediction Tracking
Coming Soon for KTTA
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for KTTA
Key Factors Influencing KTTA Stock
Bullish Factors
- Revenue growth of 15.0% year-over-year
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $3.00.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for KTTA
Frequently Asked Questions
What is KTTA stock price today?
KTTA (Pasithea Therapeutics Corp) stock is trading at $0.74 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is KTTA stock going up or down today?
KTTA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy KTTA stock now?
The decision to buy KTTA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is KTTA a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for KTTA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is KTTA stock overvalued or undervalued?
Use our DCF valuation calculator to determine if KTTA is overvalued or undervalued based on fundamental analysis and future cash flow projections.
What is KTTA's P/E ratio?
P/E ratio data for KTTA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.
What is KTTA's market cap?
KTTA (Pasithea Therapeutics Corp) has a market capitalization of $0.02 billion, making it a small-cap stock.
What is KTTA's price to book ratio?
KTTA trades at a price-to-book (P/B) ratio of 0.34, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does KTTA pay dividends?
KTTA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is KTTA's dividend yield?
KTTA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is KTTA stock a good long-term investment?
KTTA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is KTTA's revenue growth rate?
KTTA has shown revenue growth of 15.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is KTTA profitable?
Profitability metrics for KTTA are available on our dashboard with complete income statement analysis.
What are the risks of investing in KTTA?
Key risks for KTTA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does KTTA compare to its competitors?
Compare KTTA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KTTA's performance and positioning.
What is KTTA's stock price target for 2026?
Our AI model provides price targets for KTTA based on fundamental analysis: Bull case $0.97 (+30%), Base case $0.85 (+15%), Bear case $0.67 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about KTTA?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for KTTA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is KTTA's next earnings report?
KTTA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.